Skip to main content
. 2012 Mar 22;3:48. doi: 10.3389/fphar.2012.00048

Figure 4.

Figure 4

Bilirubin inhibits cell cycle progression of human vascular SMCs. Cells were treated with serum (20%) in the absence or presence of bilirubin (0–50 μM) for 24 h. Results are means ± SEM (n = 4). *Statistically significant effect of bilirubin.